RBC Capital analyst Leonid Timashev maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report) today and set a price target of ...

Investing.com -- Galderma Group AG has been downgraded by RBC Capital Markets to "sector perform" from "outperform," ...

RBC Capital initiated coverage of Karman (KRMN) with an Outperform rating and $35 price target target. Karman is a leading merchant supplier ...

Royal Bank of Canada beat estimates on higher results in its capital-markets and wealth-management divisions as both units ...

RBC Capital Markets head of U.S. equity strategy research Lori Calvasina there's a rising risk of what she calls a growth scare, which would drag the S&P 500 between 14% and 20% from its peak. But she ...

Constellation Brands' (STZ) beer business likely faced several pressures in the fiscal fourth quarter, prompting the company to lower its growth outlook for the division when it reports results next ...

Frances Donald, RBC Capital Markets chief economist and Adam Phillips, EP Wealth Advisors managing director of investments, ...

Three of Canada's big five lenders - Royal Bank of Canada, TD Bank and CIBC - on Thursday beat analyst expectations for ...

Popular, Inc. (NASDAQ: BPOP) announced today that it will participate in the upcoming RBC Capital Markets Global Financial ...

RBC Capital Markets Financial Institutions Conference March 4, 2025 8:00 AM ETCompany ParticipantsDave McKay - ...

Find insight on Aramco, Shell, crude futures and more in the latest Market Talks covering Energy and Utilities.

Toronto-Dominion Bank beat estimates on better-than-expected wealth-management and capital-markets results, capping off an ...